Medication Guide - 2/19/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Qudexy XR Topiramate CAPSULE, EXTENDED RELEASE;ORAL 205122 UPSHER SMITH LABS 02/18/2021 Brilinta Ticagrelor TABLET;ORAL 022433 ASTRAZENECA PHARMS 02/17/2021 Epzicom Abacavir Sulfate; LAmivudine TABLET;ORAL 021652 VIIV HLTHCARE 02/17/2021 Tecentriq Atezolizumab INJECTABLE;INJECTION 761034 GENENTECH INC 02/17/2021 Trizivir Abacavir Sulfate; LAmivudine; Zidovudine TABLET;ORAL 021205 VIIV HLTHCARE 02/17/2021 Dilantin-125 Phenytoin SUSPENSION;ORAL 008762 UPJOHN 02/16/2021 Dilantin-30 Phenytoin SUSPENSION;ORAL 008762 UPJOHN 02/16/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA